Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II) von Norgren, L, Hiatt, W.R, Dormandy, J.A, Nehler, M.R, Harris, K.A, Fowkes, F.G.R

Volltext

Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II) von Norgren, L, Hiatt, W.R, Dormandy, J.A, Nehler, M.R, Harris, K.A, Fowkes, F.G.R

Volltext

Impact of peripheral arterial disease in patients with diabetes—Results from PROactive (PROactive 11) von Dormandy, J.A, Betteridge, D.J, Schernthaner, G, Pirags, V, Norgren, L

Volltext

The Next 10 years in the Management of Peripheral Artery Disease: Perspectives from The ‘PAD 2009’ Conference von Norgren, L, Hiatt, W.R, Dormandy, J.A, Hirsch, A.T, Jaff, M.R, Diehm, C, Baumgartner, I, Belch, J.J.F

Volltext

Reprinted Article “The Fate of the Claudicant—A Prospective Study of 1969 Claudicants” von Dormandy, J.A, Murray, G.D

Volltext

High-density lipoprotein-cholesterol and not HbA1c was directly related to cardiovascular outcome in PROactive von Ferrannini, E., Betteridge, D. J., Dormandy, J. A., Charbonnel, B., Wilcox, R. G., Spanheimer, R., Erdmann, E., DeFronzo, R. A., Laakso, M.

Volltext

PROactive 06: cost-effectiveness of pioglitazone in Type 2 diabetes in the UK von Valentine, W. J., Bottomley, J. M., Palmer, A. J., Brändle, M., Foos, V., Williams, R., Dormandy, J. A., Yates, J., Tan, M. H., Massi-Benedetti, M.

Volltext

Arteriogenic gene therapy in patients with unreconstructable critical limb ischemia : A randomized, placebo-controlled clinical trial of adenovirus 5-delivered fibroblast growth fa... von MATYAS, L, SCHULTE, K.-L, DORMANDY, J. A, NORGREN, L, SOWADE, O, GRÖTZBACH, G, PALMER-KAZEN, U, RUBANYI, G. M, WAHLBERG, E

Volltext

Results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial von Belch, Jill J.F., MD, FRCP, Dormandy, John, MD, FRCS

Volltext

The effect of pioglitazone on recurrent myocardial infarction in 2,445 patients with type 2 diabetes and previous myocardial infarction: results from the PROactive (PROactive 05) S... von Erdmann, Erland, Dormandy, John A, Charbonnel, Bernard, Massi-Benedetti, Massimo, Moules, Ian K, Skene, Allan M

Volltext

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised... von Dormandy, John A, Charbonnel, Bernard, Eckland, David JA, Erdmann, Erland, Massi-Benedetti, Massimo, Moules, Ian K, Skene, Allan M, Tan, Meng H, Lefèbvre, Pierre J, Murray, Gordon D, Standl, Eberhard, Wilcox, Robert G, Wilhelmsen, Lars, Betteridge, John, Birkeland, Kåre, Golay, Alain, Heine, Robert J, Korányi, László, Laakso, Markku, Mokáň, Marián, Norkus, Antanas, Pirags, Valdis, Podar, Toomas, Scheen, André, Scherbaum, Werner, Schernthaner, Guntram, Schmitz, Ole, Škrha, Jan, Smith, Ulf, Tatoň, Jan

Volltext

Mediastinal mass mimicking a tumor in a patient with bladder cancer after bacillus Calmette-Guerin treatment von SOMOSKOVI, A, CARLYN, C, DORMANDY, J, SALFINGER, M

Volltext

Pioglitazone Use and Heart Failure in Patients With Type 2 Diabetes and Preexisting Cardiovascular Disease: Data from the PROactive Study (PROactive 08) von Erdmann, Erland, Charbonnel, Bernard, Wilcox, Robert G, Skene, Allan M, Massi-Benedetti, Massimo, Yates, John, Tan, Meng, Spanheimer, Robert, Standl, Eberhard, Dormandy, John A

Volltext

Thromboelastography: a reliable test? von Vig, S, Chitolie, A, Bevan, D H, Halliday, A, Dormandy, J

Volltext

The prevalence of thrombophilia in patients with symptomatic peripheral vascular disease von Vig, S., Chitolie, A., Bevan, D., Dormandy, J., Thompson, M. M., Halliday, A.

Volltext

Transatlantic Conference on Clinical Trial Guidelines in Peripheral Arterial Disease: clinical trial methodology. Basel PAD Clinical Trial Methodology Group von Labs, K H, Dormandy, J A, Jaeger, K A, Stuerzebecher, C S, Hiatt, W R

Volltext

Randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of AS-013, a prostaglandin E1 prodrug, in patients with Intermittent claudication von BELCH, J. J. F, BELL, P. R. F, CREISSEN, D, DORMANDY, J. A, KESTER, R. C, MCCOLLUM, R. D, MIZUSHIMA, Y, RUCKLEY, C. V, SCURR, J. H, WOLFE, J. H. N

Volltext

PROactive study von Dormandy, J, Charbonnel, B, Eckland, D, Erdmann, E

Volltext

Prevalence and Risk of Thrombophilia Defects in Vascular Patients von Vig, S, Chitolie, A, Sleight, S, Bevan, D, Dormandy, J, Thompson, M.M, Halliday, A

Volltext

Oxpentifylline treatment of venous ulcers of the leg von Colgan, M P, Dormandy, J A, Jones, P W, Schraibman, I G, Shanik, D G, Young, R A

Volltext